GAC - The only thing missing in your commentary is if BETonMACE shows increases in cognitive function on the Alzheimer's leg of the trial. When Biogen's news came out the other day that showed they were just able to stop progression thier market cap went up $11 billion at one point.
Agree with all other points in your post.
Does anyone know if secondary end points are announced at the time of Top Line results?
tada